Hippocratic AI Raises $126 Million Series C Led by A16z to Expand Safe Generative AI Healthcare Agents
- ByStartupStory | November 4, 2025
Hippocratic AI Raises $126 Million Series C Led by A16z to Expand Safe Generative AI Healthcare Agents
Palo Alto-based Hippocratic AI, a leader in clinically safe, generative AI healthcare agents, announced it has secured $126 million in its latest Series C funding round, valuing the company at $3.5 billion. The round was led by growth equity firm Avenir Growth and featured participation from prominent investors including Andreessen Horowitz (a16z), CapitalG (Google’s growth fund), General Catalyst, Kleiner Perkins, Premji Invest, Universal Health Services, Cincinnati Children’s Hospital Medical Center, WellSpan Health, and notable angel investors such as John Doerr and Rick Klausner.
Since commercial launch just 15 months ago, Hippocratic AI has rapidly built a portfolio of over 1,000 clinical AI use cases across six countries and established partnerships with more than 50 large health systems, payors, and pharmaceutical companies. Its AI agents have already completed 115 million clinical patient interactions without any safety incidents, showcasing the company’s commitment to responsible and trustworthy AI deployment in healthcare.
Hippocratic AI specializes in creating patient-facing AI agents that support clinical workflows without crossing into diagnostic or prescribing tasks. Its unique approach combines clinician expertise and practical healthcare insights with advanced AI safety validation, ensuring the agents enhance care quality while mitigating risks.
CEO Munjal Shah highlighted that the new funding will accelerate the development and deployment of generative AI-driven super staffing, enabling healthcare organizations to scale clinical services safely and efficiently in response to growing demand and workforce shortages.
Investors see Hippocratic AI as a category leader at the intersection of AI innovation and healthcare safety, with Avenir Growth co-founder Andrew Sugrue stating that Hippocratic’s relentless focus on safety has earned the trust of healthcare executives worldwide.
In summary, Hippocratic AI’s $126 million Series C round, with a16z as a key investor, marks a significant milestone underscoring the growing confidence in safe, scalable AI solutions for healthcare. The funding will empower the company to expand its product offerings and market reach, advancing its vision of making healthcare AI agents abundant, reliable, and widely accessible.
Follow Startup Story
Related Posts
